StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
46
Publishing Date
2023 - 07 - 27
1
2023 - 07 - 18
1
2023 - 06 - 21
1
2023 - 06 - 08
1
2023 - 05 - 16
1
2023 - 05 - 01
2
2023 - 04 - 26
1
2023 - 03 - 23
1
2023 - 03 - 21
1
2023 - 03 - 06
1
2023 - 02 - 22
1
2023 - 02 - 21
1
2023 - 02 - 08
1
2023 - 02 - 03
1
2023 - 01 - 24
1
2023 - 01 - 12
1
2023 - 01 - 04
1
2022 - 12 - 14
1
2022 - 12 - 12
1
2022 - 12 - 05
1
2022 - 11 - 17
2
2022 - 11 - 08
1
2022 - 11 - 07
1
2022 - 11 - 03
1
2022 - 10 - 31
1
2022 - 10 - 27
1
2022 - 10 - 13
1
2022 - 10 - 11
1
2022 - 09 - 14
1
2022 - 09 - 12
3
2022 - 09 - 08
1
2022 - 09 - 07
1
2022 - 09 - 06
1
2022 - 09 - 01
2
2022 - 07 - 15
1
2022 - 06 - 22
1
2022 - 05 - 24
1
2022 - 05 - 23
1
2022 - 04 - 25
2
2022 - 04 - 22
1
Sector
Commercial services
3
Consumer non-durables
2
Consumer services
1
Energy minerals
1
Finance
1
Health technology
27
Information
2
Manufacturing
6
Miscellaneous
1
N/a
2
Non-energy minerals
1
Producer manufacturing
1
Professional, scientific, and technical services
2
Retail trade
1
Wholesale trade
1
Tags
Acquisition
3
Al102
1
Alliances
1
Alzheimer's
2
Alzheimer’s
2
America
1
Aml
1
Amt-101
1
Approval
1
Asco
1
Association
1
Ayvakit
1
Biocanada
1
Biopharma
1
Biotech
1
Biotech-bay
3
Biotech-beach
3
Blincyto
1
Brands
1
Cancer
2
Cardiology
1
Care
1
Chmp
1
Clinical-trials-phase-i
1
Clinical-trials-phase-ii
1
Clinical-trials-phase-iii
1
Conference
1
Dermatitis
1
Designation
2
Diabetes
1
Diabetic
1
Disease
3
Drug
1
Ema
1
Events
2
Eyp-1901
1
Fda
1
Fda-approvals
1
Fibrosis
1
Filsuvez
1
Gartner
1
Gemcitabine
1
Growth
2
Market
2
Meeting
2
N/a
23
Pharm-country
3
Phase 1
4
Phase 2
4
Phase 2b
2
Positive
34
Research
3
Results
5
Study
5
System
3
Therapeutics
4
Topline
5
Treatment
6
Trial
11
Week
2
Entities
180 degree capital corp.
1
Actinium pharmaceuticals, inc.
1
Altimmune, inc.
1
Amgen inc.
2
Amryt pharma plc
1
Annovis bio, inc.
1
Applied molecular transport inc.
1
Arrival
2
Astrazeneca plc
1
Avenue therapeutics, inc.
1
Avrupa minerals ltd.
1
Ayala pharmaceuticals, inc.
1
Bannix acquisition corp.
1
Beigene, ltd.
2
Blueprint medicines corporation
1
Carnival corporation
1
Cassava sciences, inc.
1
Chemocentryx, inc.
2
Comscore, inc.
1
Darkpulse, inc.
1
Dsg global inc.
1
Eyepoint pharmaceuticals, inc.
1
Femasys inc
1
Flowserve corporation
1
Fortress biotech, inc.
1
Gartner, inc.
1
Glaukos corporation
1
Glaxosmithkline plc
1
Greene concepts, inc
1
Hoth therapeutics, inc.
1
Immix biopharma, inc.
1
Ix acquisition corp.
1
Kering
2
Longboard pharmaceuticals inc
1
Lvmh moet hennessy louis vuitton
1
Momentive global inc
1
Motus gi holdings, inc.
1
Nevro corp.
1
Nkarta, inc.
1
Painreform ltd.
1
Pan american silver corp.
1
Panbela therapeutics inc
1
Pds biotechnology corporation
1
Pliant therapeutics, inc.
1
Pulmatrix, inc.
1
Pvh corp.
1
Redhill biopharma ltd.
1
Regulus therapeutics inc.
1
Theratechnologies inc.
1
Timber pharmaceuticals, inc.
1
Vir biotechnology, inc.
1
W&t offshore, inc.
1
Windtree therapeutics, inc.
1
Xencor, inc.
1
Xylem inc.
1
Zentalis pharmaceuticals, inc.
1
Symbols
ALT
1
AMGN
2
AMTI
1
AMYT
1
ANVS
1
ARVL
2
ATNM
1
ATXI
1
AVPMF
1
AYLA
1
AZN
1
AZNCF
1
BEIGF
1
BGNE
2
BNIX
1
BPMC
1
CCL
1
CCXI
2
CUK
1
DPLS
1
DSGT
1
EYPT
1
FBIO
1
FEMY
1
FLS
1
GKOS
1
GLAXF
1
GSK
1
HOTH
1
IMMX
1
INKW
1
IT
1
IXAQ
1
LBPH
1
LVMHF
1
LVMUY
1
MNTV
1
MOTS
1
NKTX
1
NVRO
1
PAAS
1
PBLA
1
PDSB
1
PLRX
1
PPRUF
2
PPRUY
2
PRFX
1
PULM
1
PVH
1
RDHL
1
RGLS
1
SAVA
1
SCOR
1
THTX
1
TMBR
1
TURN
1
VIR
1
WINT
1
WTI
1
XNCR
1
Exchanges
Amex
3
Nasdaq
38
Nyse
8
Crawled Date
2023 - 07 - 27
1
2023 - 07 - 18
1
2023 - 06 - 21
1
2023 - 06 - 08
1
2023 - 05 - 16
1
2023 - 05 - 01
2
2023 - 04 - 26
1
2023 - 03 - 23
1
2023 - 03 - 21
1
2023 - 03 - 06
1
2023 - 02 - 22
1
2023 - 02 - 21
1
2023 - 02 - 08
1
2023 - 02 - 03
1
2023 - 01 - 24
1
2023 - 01 - 12
1
2023 - 01 - 04
1
2022 - 12 - 14
1
2022 - 12 - 12
1
2022 - 12 - 05
1
2022 - 11 - 17
2
2022 - 11 - 08
1
2022 - 11 - 07
1
2022 - 11 - 03
1
2022 - 10 - 31
1
2022 - 10 - 27
1
2022 - 10 - 13
1
2022 - 10 - 11
1
2022 - 09 - 14
1
2022 - 09 - 12
3
2022 - 09 - 08
1
2022 - 09 - 07
1
2022 - 09 - 06
1
2022 - 09 - 01
2
2022 - 07 - 15
1
2022 - 06 - 22
1
2022 - 05 - 30
1
2022 - 05 - 23
1
2022 - 04 - 25
2
2022 - 04 - 22
1
Crawled Time
00:00
58
00:20
13
01:00
31
02:00
16
03:00
11
04:00
10
04:20
6
05:00
18
06:00
43
07:00
50
08:00
46
08:20
7
09:00
46
10:00
41
11:00
259
11:01
3
11:03
2
12:00
520
12:01
5
12:03
8
12:04
2
12:07
2
12:15
42
12:20
117
12:30
74
12:58
2
13:00
358
13:01
5
13:02
3
13:05
2
13:07
2
13:14
2
13:15
30
13:20
82
13:30
82
13:35
2
14:00
231
14:01
9
14:15
20
14:20
46
14:30
43
15:00
135
15:15
7
15:20
22
15:30
36
16:00
86
16:01
3
16:20
36
17:00
112
18:00
84
19:00
63
20:00
124
20:20
25
21:00
166
21:06
5
22:00
149
22:01
3
22:12
3
22:13
5
23:00
90
Source
spacfeed.com
1
www.avrupaminerals.com
1
www.biospace.com
23
www.globenewswire.com
12
www.prnewswire.com
9
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
positive
crawled time :
14:20
save search
Fly Play hf.: Operational profit, growing revenue, and healthy cash position in the second quarter
Published:
2023-07-27
(Crawled : 14:20)
- globenewswire.com
ARVL
|
News
|
$0.49
0.37%
2.5M
|
Manufacturing
|
-71.35%
|
O:
6.77%
H:
0.0%
C:
0.0%
growing
Continued Positive Performance of Novel Drug Development by Annovis Bio Presented at 2023 Alzheimer's Association International Conference
Published:
2023-07-18
(Crawled : 14:20)
- biospace.com/
ANVS
|
$10.09
2.44%
-0.15%
220K
|
Health Technology
|
-25.59%
|
O:
1.63%
H:
1.99%
C:
0.36%
drug
conference
association
positive
international
alzheimer's
FDA GRANTS FULL APPROVAL FOR BLINCYTO® (BLINATUMOMAB) TO TREAT MINIMAL RESIDUAL DISEASE-POSITIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
Published:
2023-06-21
(Crawled : 14:20)
- biospace.com/
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
-32.39%
|
O:
-0.8%
H:
0.36%
C:
-2.33%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
17.65%
|
O:
-0.18%
H:
0.8%
C:
-0.5%
blincyto
fda
approval
treat
grants
leukemia
180 Degree Capital Corp. Presents Analysis Supporting Position That the Returns of Preferred Stockholders of Comscore, Inc. Would Benefit Substantially From a Higher Common Stock Price
Published:
2023-06-08
(Crawled : 14:20)
- globenewswire.com
SCOR
|
$14.66
-4.0%
-4.16%
13K
|
Commercial Services
|
1453.76%
|
O:
-2.03%
H:
0.98%
C:
-2.3%
TURN
|
$3.98
-0.25%
4.8K
|
Finance
|
-13.67%
|
O:
0.87%
H:
1.61%
C:
-3.87%
Early Feedback is Positive as Holland America Line Installs SpaceX's Starlink on First Ship in Alaska
Published:
2023-05-16
(Crawled : 14:20)
- prnewswire.com
CUK
|
News
0 d
|
$12.73
-0.55%
-0.47%
1.1M
|
Consumer Services
|
38.67%
|
O:
-1.09%
H:
4.26%
C:
1.65%
CCL
|
News
0 d
|
$14.12
-0.42%
0.0%
29M
|
Consumer Services
|
36.95%
|
O:
-0.48%
H:
3.7%
C:
0.97%
america
positive
PainReform Announces Positive Safety Data in First Part of Phase 3 Clinical Trial of PRF-110 in Patients Undergoing Bunionectomy Surgery
Published:
2023-05-01
(Crawled : 14:20)
- globenewswire.com
PRFX
1 d
|
$0.8737
-1.83%
-1.87%
29K
|
Health Technology
|
-84.43%
|
O:
17.2%
H:
8.7%
C:
-0.15%
prf-110
positive
Women Apparel Market size to grow by USD 188.13 billion from 2022 to 2027, Premiumization through well-positioned brands to drive market growth - Technavio
Published:
2023-05-01
(Crawled : 14:20)
- prnewswire.com
PPRUF
|
$358.55
37.56%
1.5K
|
Consumer Non-Durables
|
-43.87%
|
O:
1.1%
H:
0.03%
C:
-1.95%
LVMHF
|
News
|
$854.0
3.7%
590
|
Consumer Non-Durables
|
-11.74%
|
O:
-0.53%
H:
0.92%
C:
-0.05%
PPRUY
|
$36.0023
-0.11%
220K
|
Manufacturing
|
-42.91%
|
O:
0.0%
H:
0.4%
C:
0.08%
LVMUY
|
News
|
$168.5633
-8.78%
180K
|
Retail Trade
|
-12.4%
|
O:
1.14%
H:
0.0%
C:
-1.48%
PVH
|
News
F
|
$106.78
0.44%
0.0%
910K
|
Consumer Non-Durables
|
24.44%
|
O:
-0.52%
H:
1.45%
C:
-1.39%
brands
women
growth
market
Zentalis to present positive clinical data in ovarian cancer combining azenosertib and chemotherapy, including clinical support for Cyclin E1 expression as predictive marker for clinical benefit from azenosertib at the 2023 ASCO Annual Meeting
Published:
2023-04-26
(Crawled : 14:20)
- globenewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
6.15%
|
O:
-4.57%
H:
0.22%
C:
-1.98%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
7.69%
|
O:
-0.03%
H:
0.3%
C:
-2.63%
ZNTL
|
$12.97
3.43%
3.32%
1M
|
Health Technology
|
-40.52%
|
O:
-0.23%
H:
0.18%
C:
-1.43%
asco
positive
cancer
meeting
Nexcella Announces New Positive NXC-201 Clinical Data Demonstrating 100% Complete Responses in AL Amyloidosis Patients
Published:
2023-03-23
(Crawled : 14:20)
- biospace.com/
IMMX
|
$2.21
0.0%
64K
|
|
2.34%
|
O:
0.93%
H:
3.06%
C:
-8.8%
nxc-201
positive
Altimmune Announces Positive Results from Week 24 Interim Analysis of Pemvidutide MOMENTUM Phase 2 Obesity Trial and 12-Week Phase 1b Type 2 Diabetes Safety Trial
Published:
2023-03-21
(Crawled : 14:20)
- biospace.com/
ALT
|
$6.91
0.29%
0.29%
3.6M
|
Commercial Services
|
-36.72%
|
O:
-37.27%
H:
1.31%
C:
-27.74%
obesity
momentum
positive
week
trial
diabetes
results
Bannix Acquisition Corp. Announces Clarifies Position on Excise … – EIN News
Published:
2023-03-06
(Crawled : 14:20)
- spacfeed.com
BNIX
|
News
|
$11.0
0.45%
2
|
|
5.49%
|
O:
0.0%
H:
0.1%
C:
0.1%
IXAQ
|
News
|
$11.295
0.04%
3.7K
|
n/a
|
10.22%
|
O:
0.0%
H:
0.29%
C:
0.0%
WTI
|
$2.41
1.26%
0.0%
1.5M
|
Energy Minerals
|
-61.56%
|
O:
-2.07%
H:
0.98%
C:
-2.28%
acquisition
Vir Biotechnology Announces Positive Final Draft Guidance on Sotrovimab from the UK’s National Institute for Health and Care Excellence (NICE)Final draft guidance based on cost effectiveness evaluation of sotrovimab
Published:
2023-02-22
(Crawled : 14:20)
- biospace.com/
XNCR
|
$18.385
-2.98%
-3.07%
830K
|
Health Technology
|
-46.16%
|
O:
0.06%
H:
2.11%
C:
0.2%
VIR
|
$7.96
0.0%
1.1M
|
Health Technology
|
-70.54%
|
O:
0.04%
H:
3.96%
C:
0.04%
care
health
positive
Nokia and Bosch set a new bar for 5G positioning and look ahead to 6G #MWC23
Published:
2023-02-21
(Crawled : 14:20)
- globenewswire.com
ARVL
|
News
|
$0.49
0.37%
2.5M
|
Manufacturing
|
62.7%
|
O:
-5.44%
H:
0.0%
C:
0.0%
mwc23
set
Avrupa Minerals to Continue Positive Progress in Finland, Portugal, and Kosovo in 2023
Published:
2023-02-08
(Crawled : 14:20)
- avrupaminerals.com
AVPMF
|
$0.012
420.0%
18K
|
Miscellaneous
|
Email alert
Add to watchlist
positive
Blueprint Medicines to Present Positive Data from PIONEER Trial of AYVAKIT® (avapritinib) in Indolent Systemic Mastocytosis at 2023 AAAAI Annual Meeting
Published:
2023-02-03
(Crawled : 14:20)
- prnewswire.com
BPMC
|
$86.87
-2.28%
-2.34%
800K
|
Health Technology
|
77.03%
|
O:
-2.06%
H:
2.62%
C:
-4.99%
ayvakit
meeting
trial
positive
Cassava Sciences Announces Positive Top-Line Clinical Results in Phase 2 Study Evaluating Simufilam in Alzheimer’s Disease
Published:
2023-01-24
(Crawled : 14:20)
- globenewswire.com
SAVA
|
$19.61
-7.46%
-8.06%
1.3M
|
Health Technology
|
-46.1%
|
O:
-6.97%
H:
1.97%
C:
-13.16%
sciences
disease
alzheimer’s
positive
results
study
phase 2
Silver Viper Presents Highly Positive Geophysical and Geochemical Survey Results at La Virginia
Published:
2023-01-12
(Crawled : 14:20)
- prnewswire.com
PAAS
|
$19.07
0.05%
-0.47%
4.1M
|
Non-Energy Minerals
|
4.44%
|
O:
1.59%
H:
0.59%
C:
-0.22%
positive
results
Pulmatrix Announces Positive Top Line Results from a Phase 1 Study with PUR3100, a Novel Orally Inhaled Dihydroergotamine (DHE), for Acute Migraine
Published:
2023-01-04
(Crawled : 14:20)
- prnewswire.com
PULM
|
$2.0
2.04%
2.0%
12K
|
Health Technology
|
-53.29%
|
O:
-17.61%
H:
13.96%
C:
6.27%
pur3100
migraine
positive
study
phase 1
Panbela Receives Positive EMA Opinion on Orphan Designation for Ivospemin (SBP-101) in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Ductal Adenocarcinoma
Published:
2022-12-14
(Crawled : 14:20)
- globenewswire.com
PBLA
|
$0.4895
-6.31%
66K
|
Professional, Scientific, and T...
|
-99.75%
|
O:
30.91%
H:
36.67%
C:
-33.78%
sbp-101
designation
ema
gemcitabine
positive
pancreatic
Femasys Inc. Reports Encouraging Promotional Launch of FemCerv at AAGL Based on Positive Reception by Gynecologic Physicians and Surgeons
Published:
2022-12-12
(Crawled : 14:20)
- biospace.com/
FEMY
|
$1.33
1.53%
1.5%
160K
|
Manufacturing
|
22.22%
|
O:
8.33%
H:
0.0%
C:
-7.69%
positive
← Previous
1
2
3
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
GBR
|
$1.42
31.48%
11.27%
990K
|
Energy Minerals
KUKE
|
$2.88
2.49%
7.64%
360K
|
CXM
4
|
$11.34
-0.44%
4.27%
1.7M
|
Information
PVL
4
|
$1.47
-0.68%
4.08%
77K
|
Energy Minerals
RNR
4
|
$224.74
0.85%
3.52%
310K
|
Finance
BSBR
|
$5.25
2.54%
0.38%
430K
|
Finance
DV
|
News
|
$29.43
-2.36%
0.24%
1.9M
|
Information
JOE
4
|
$54.88
1.22%
0.22%
210K
|
Finance
JEF
4
|
$42.17
1.57%
0.07%
1.8M
|
Finance
MUSA
4
|
$417.23
1.06%
0.01%
170K
|
Retail Trade
Your saved searches
Save your searches and get alerts when important news are released.